SE8301039L - Heterocykliska derivat - Google Patents

Heterocykliska derivat

Info

Publication number
SE8301039L
SE8301039L SE8301039A SE8301039A SE8301039L SE 8301039 L SE8301039 L SE 8301039L SE 8301039 A SE8301039 A SE 8301039A SE 8301039 A SE8301039 A SE 8301039A SE 8301039 L SE8301039 L SE 8301039L
Authority
SE
Sweden
Prior art keywords
alkyl
group
substituted
oxygen
sulphur
Prior art date
Application number
SE8301039A
Other languages
English (en)
Swedish (sv)
Other versions
SE8301039D0 (sv
Inventor
J W Clitherow
B J Price
R Hayes
D E Bays
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8301039D0 publication Critical patent/SE8301039D0/xx
Publication of SE8301039L publication Critical patent/SE8301039L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8301039A 1982-02-24 1983-02-24 Heterocykliska derivat SE8301039L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8205431 1982-02-24
GB8205723 1982-02-26

Publications (2)

Publication Number Publication Date
SE8301039D0 SE8301039D0 (sv) 1983-02-24
SE8301039L true SE8301039L (sv) 1983-08-25

Family

ID=26282061

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8301039A SE8301039L (sv) 1982-02-24 1983-02-24 Heterocykliska derivat

Country Status (18)

Country Link
JP (1) JPS58157772A (it)
AU (1) AU1180383A (it)
BE (1) BE896012A (it)
DE (1) DE3306503A1 (it)
DK (1) DK88283A (it)
ES (2) ES8407030A1 (it)
FI (1) FI830609L (it)
FR (1) FR2521993B1 (it)
GB (1) GB2116178B (it)
GR (1) GR77048B (it)
IL (1) IL67990A0 (it)
IT (1) IT1167622B (it)
LU (1) LU84659A1 (it)
NL (1) NL8300697A (it)
NO (1) NO830643L (it)
NZ (1) NZ203384A (it)
PT (1) PT76280A (it)
SE (1) SE8301039L (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336410A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Sulfenamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2815346B1 (fr) * 2000-10-13 2004-02-20 Servier Lab Nouveaux composes aminotriazolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3067920D1 (en) * 1979-03-02 1984-06-28 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
GB2063874B (en) * 1979-10-22 1983-09-28 Glaxo Group Ltd Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them
EP0029303B1 (en) * 1979-10-22 1985-01-30 Glaxo Group Limited 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
EP0029306B1 (en) * 1979-10-23 1984-07-25 Glaxo Group Limited Aminoalkyl compounds, their production and pharmaceutical compositions containing them
FR2477150A1 (fr) * 1980-02-28 1981-09-04 Glaxo Group Ltd Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant

Also Published As

Publication number Publication date
IT8347786A0 (it) 1983-02-24
GB2116178B (en) 1985-10-02
IT1167622B (it) 1987-05-13
FR2521993A1 (fr) 1983-08-26
ES526532A0 (es) 1985-11-16
DK88283A (da) 1983-08-25
NL8300697A (nl) 1983-09-16
JPS58157772A (ja) 1983-09-19
AU1180383A (en) 1983-09-01
BE896012A (fr) 1983-08-24
FR2521993B1 (fr) 1988-09-16
PT76280A (en) 1983-03-01
NO830643L (no) 1983-08-25
LU84659A1 (fr) 1984-11-08
GB8305147D0 (en) 1983-03-30
GR77048B (it) 1984-09-04
NZ203384A (en) 1985-08-16
ES8602702A1 (es) 1985-11-16
DK88283D0 (da) 1983-02-24
SE8301039D0 (sv) 1983-02-24
DE3306503A1 (de) 1983-09-01
GB2116178A (en) 1983-09-21
FI830609L (fi) 1983-08-25
ES520031A0 (es) 1984-04-01
ES8407030A1 (es) 1984-04-01
FI830609A0 (fi) 1983-02-24
IL67990A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
ES476305A1 (es) Un procedimiento para la preparacion de nuevos derivados aminicos
MX9203165A (es) Derivados de succinimida y composicion farmaceutica que los contiene .
SE7903698L (sv) Heterocykliska foreningar
PT1289955E (pt) Piperidinas para utilizacao como antagonistas dos receptores da orexina
ATE190052T1 (de) Thiazolidindione-derivate, ihre herstellung und verwendung
ES476658A1 (es) Procedimiento para preparar derivados de sulfonamido-piridi-na
SE7906372L (sv) Heterocykliska foreningar
NZ212231A (en) Cephalosporin derivatives; intermediates and pharmaceutical compositions
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
SE8301039D0 (sv) Heterocykliska derivat
IE811965L (en) Tetrazoles
DE3381243D1 (de) Aminopyrimidinone als histamin-h2-antagonisten.
ATE34978T1 (de) Imidazolinon-derivate als histamin-h2antagonisten.
ATE13886T1 (de) Pyridinderivate als histamin-h2-antagonisten.
NO920619L (no) Oxazinobenzazolforbindelser
GB2014561A (en) Amine derivatives, their preparation and pharmaceutical compositions containing them
FI803970L (fi) Nya substituerade 4-amino-2,6-diaryl-tetrahydrotiopyraner deras syraadditionssalter deras framstaellningsfoerfarande deras anvaendning och farmaceutiska blandningar
ES529415A0 (es) Procedimiento para la preparacion de derivados de piridin-pirimidinona
DE69102309D1 (de) N-cycloalkyl-Alkylamine, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und Zwischenprodukte zu ihrer Synthese.
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
RO82994B1 (ro) Compozitie erbicida cu antidot
TH4274EX (th) สารประกอบเฮทเทอร์โรไซคลิคชนิดใหม่

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8301039-7

Format of ref document f/p: F